Rockwell Medical Investor Relations Material
Latest events
Q1 2025
Rockwell Medical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Rockwell Medical Inc
Access all reports
Rockwell Medical, Inc., biopharmaceutical company, targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. It offers dialysis concentrates/dialysates and manufactured drugs, including Triferic (ferric pyrophosphate citrate), an iron replacement product for hemodialysis; Calcitriol injection, a vitamin D analog; Soluble Ferric Pyrophosphate (SFP) injection to treat iron deficient anemia; Rockwell's GranuFlo powder for oral solution; and Hematogenix SV Dialysis tests.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
RMTI
Country
🇺🇸 United States